lobbying_activities: 821679

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
821679	2fd1e985-1986-4053-9666-1a4fcfd13733	Q3	DUTKO WORLDWIDE, LLC	12868	ABBOTT LABORATORIES	2009	third_quarter	CPT	Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Also: America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2009-10-01T10:07:26-04:00